| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGIO | Exit | AGIOS PHARMACEUTICALS INC | $0 | – | -4,833 | -100.0% | -0.06% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -23,321 | -100.0% | -0.06% | – |
| REPH | Exit | SOCIETAL CDMO INC | $0 | – | -1,689,768 | -100.0% | -0.36% | – |
| VRCA | Exit | VERRICA PHARMACEUTICALS INC | $0 | – | -259,593 | -100.0% | -0.46% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -597,513 | -100.0% | -0.98% | – |
| VRNA | Exit | VERONA PHARMA PLCsponsored ads | $0 | – | -183,064 | -100.0% | -1.37% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -1,683,836 | -100.0% | -7.07% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -910,730 | -100.0% | -9.14% | – |
| ANIK | Exit | ANIKA THERAPEUTICS INC | $0 | – | -1,081,360 | -100.0% | -9.25% | – |
| FLDM | Exit | STANDARD BIOTOOLS INC | $0 | – | -7,622,413 | -100.0% | -10.15% | – |
| Exit | INTERCEPT PHARMACEUTICALS INCput | $0 | – | -1,200,000 | -100.0% | -10.22% | – | |
| Exit | ALIMERA SCIENCES INC | $0 | – | -16,835,154 | -100.0% | -23.97% | – | |
| LQDA | Exit | LIQUIDIA CORP | $0 | – | -9,243,627 | -100.0% | -26.91% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIQUIDIA CORP | 4 | Q3 2023 | 49.0% |
| ANIKA THERAPEUTICS INC | 4 | Q3 2023 | 14.6% |
| STANDARD BIOTOOLS INC | 4 | Q3 2023 | 11.7% |
| EVOLUS INC | 4 | Q3 2023 | 10.9% |
| ALIMERA SCIENCES INC | 4 | Q3 2023 | 24.0% |
| ADMA BIOLOGICS INC | 4 | Q3 2023 | 8.6% |
| VERONA PHARMA PLC | 4 | Q3 2023 | 4.0% |
| SOCIETAL CDMO INC | 4 | Q3 2023 | 2.0% |
| AGIOS PHARMACEUTICALS INC | 4 | Q3 2023 | 0.1% |
| EXELIXIS INC | 3 | Q3 2023 | 11.5% |
View Caligan Partners LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ALIMERA SCIENCES INC | August 03, 2023 | 17,635,154 | 33.1% |
| EXELIXIS, INC. | June 02, 2023 | 910,730 | 0.3% |
| ADMA BIOLOGICS, INC. | December 09, 2022 | 10,264,311 | 4.6% |
| AMAG PHARMACEUTICALS, INC. | November 16, 2020 | ? | ? |
| Knowles Corp | September 30, 2019 | 102,674 | 0.0% |
View Caligan Partners LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-04 |
| 4 | 2024-05-30 |
| SC 13D/A | 2024-05-30 |
| 13F-HR | 2024-05-13 |
| SC 13D/A | 2024-03-06 |
| 4 | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13D/A | 2024-01-08 |
| 4 | 2023-12-14 |
| SC 13D/A | 2023-12-14 |
View Caligan Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.